Phytovision
Natural health product licensed in Canada
- Licence holder
- SISU
- NPN or DIN-HM
- 80006335
- Status
- Inactive licence
- Licence date
- 7 July 2008
- Revision date
- 7 March 2013
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Feuille(s) Potency : 24 % Flavone Glycosides | 30 mg | Not calculated |
| Ginkgo biloba Source : Feuille(s) Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Vaccinium myrtillus Source : Fruit(s) Potency : 36 % Anthocyanosides | 25 mg | Not calculated |
| Epsilon-carotene-3 Source : fleur de calendula (Tagetes erecta) | 2 mg | Not calculated |
| Vitis vinifera Source : Graine(s) Potency : 85 % -95 % Proanthocyanidins | 25 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose - microcrystalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Promotes eye health in people with normal tension glaucoma.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80006335
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.